Primary information |
---|
ID | antitb_1730, |
Name | US 2002/013197 |
N-Terminal modification | SEQ ID NO 12 |
C-Terminal Modification | SEAYQGVQQK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Species | Protein Derived |
Strain | From the proetins containing mycobacterial CD8 T cell epitopes |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis |
Inhibition Concentration | In vitro |
Sequence | 2002 |
Cytotoxicity | PBMcs |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | β2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice |
Mechanism of Action | NA |
Target | IFN-γ release increases |
Combination Therapy | By CD8 T cell response |
Other activities | NA |
PMID | None |
Year of Publication | None |
Tertiary Structure (Technique) | Not Predicted), |